UPC Analytics
ENDE
Overview · Filed: Dec 8, 2025

UPC_CoA_917/2025

Methods of Using Sustained Release Aminopyridine Compositions

AppealsMain AppealCourt of AppealAppealOral Phase
  • 2026-01-26Procedural onlyproceduralApplication RoP262-2

    The Court of Appeal issued an order on Merz Pharmaceuticals' request under R. 262.2 RoP to keep certain information (including Exhibit 823) confidential in the Merz v. Viatris Santé proceedings. The Court reiterated that R. 262.2 RoP requests are addressed to future public access requests, not to the other party. Protection against the other party's use of confidential information requires a R. 262A RoP confidentiality order. The Court declined to issue a decision on the R. 262.2 request at this stage pending any public access application.